High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings (Q84064593)
Jump to navigation
Jump to search
scientific article published on 01 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings |
scientific article published on 01 July 2009 |
Statements
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings (English)
Kenneth H Mayer
N Kumarasamy
Vidya Madhavan
Kartik K Venkatesh
S Saravanan
Rami Kantor
P Balakrishnan
Bella Devaleenal
S Poongulali
Tokugha Yepthomi
Suniti Solomon
Constance Benson